Finerenone is a first in class nonsteroidal mineralocorticoid receptor antagonist indicated in adults with chronic kidney disease associated with type 2 diabetes mellitus.
Sara Varghese, PharmD
Advertisement
Articles by Sara Varghese, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Regular Melatonin Supplementation May Hide Hidden Heart Complications
2
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
3
COVID-19 During Pregnancy Raises Neurodevelopmental Risks in Children
4
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
5
